"FAERS data are particularly useful for identifying new (i.e., unexpected or unlabeled), rare, serious adverse events that are temporally associated with a product for which the background rate of events is low," she wrote in an email to NPR
do not use if you have a history of severe gastrointestinal disease Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness) While this is rare with GLP-1s, if it occurs, please seek in-person care immediately
GLP-1 medications represent a significant advancement in treating diabetes and obesity, but managing side effects is key to long-term success
Many patients prescribed both semaglutide (Ozempic, Wegovy, Rybelsus) and Adderall (amphetamine/dextroamphetamine) wonder whether these medications can be safely combined